Leverages CRISPRomics® to develop novel cancer therapies, including engineered TIL programs and first-in-class drug candidates.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
KSQ Therapeutics leverages its proprietary CRISPRomics® platform to discover and validate novel therapeutic targets with the potential to cure human diseases. The company advances a pipeline of CRISPR/Cas9-engineered Tumor Infiltrating Lymphocyte (eTIL®) programs and first-in-class candidates for the treatment of cancer.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
KSQ Therapeutics Management Team
KSQ Therapeutics Valuations & Financials
View real-time NPM data on KSQ Therapeutics stock including daily KSQ Therapeutics stock price estimates, valuation history, and historical share price information. Access KSQ Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track KSQ Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on KSQ Therapeutics? Get in touch to learn more.
Similar Companies
like KSQ Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Concentric Analgesics
Healthcare & Life Sciences
Develops non-opioid therapeutics that deliver durable, site-specific pain relief via a single local administration.
Picnic
Provides workflow and operations management software that streamlines tasks, collaboration, and process automation for businesses.
Dispatch Data
FinTech
Data orchestration platform that syncs client information across advisor tech stacks, eliminating the need for custom integrations.
Little Spoon
Delivers organic, nutritious, and convenient meals and snacks for babies, toddlers, and kids, tailored to every stage of childhood.
Instrumentl
Enterprise Software
Online platform that helps nonprofits find and manage grants through automated discovery, research, and tracking tools.
Carte
Designs and manufactures modular label machinery offering digital embellishment and laser die-cutting for high-quality label applications.
Techcyte
Healthcare & Life Sciences
Develops AI-powered software for digital pathology and lab diagnostics, enabling faster and more accurate medical sample analysis.
Zafran
Uncovers and acts on real risks by analyzing and automating mitigation of exploitable vulnerabilities using existing defenses.
FAQ
We have answers
KSQ Therapeutics stock does not trade on public stock exchanges. KSQ Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in KSQ Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
KSQ Therapeutics Stock does not trade on public stock exchanges. In order to sell KSQ Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
KSQ Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view KSQ Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for KSQ Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell KSQ Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in KSQ Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
KSQ Therapeutics is a private company and has not had an IPO. There is currently no KSQ Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to KSQ Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
